Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-Apr-24 5:45 PM View:  | Rocket Pharmaceuticals, Inc. (RCKT) | 15-Apr-24 | Option Exercise | 29,624 | $4.34 | $128,627.00 | 31% 95.16K to 124.78K | |
| 16-Apr-24 5:45 PM View: | Rocket Pharmaceuticals, Inc. (RCKT) | 15-Apr-24 | Option Sale | 10,000 | $24.05 | $240,520.00 | (8%) 124.78K to 114.78K | |
| 16-Apr-24 5:45 PM View: | Rocket Pharmaceuticals, Inc. (RCKT) | 12-Apr-24 | Option Exercise | 70,000 | $4.34 | $303,940.00 | 74% 95.16K to 165.16K | |
| 16-Apr-24 5:45 PM View: | Rocket Pharmaceuticals, Inc. (RCKT) | 12-Apr-24 | Option Sale | 70,000 | $24.36 | $1,705,260.00 | (42%) 165.16K to 95.16K | |
| 16-Feb-24 4:20 PM View: | Ptc Therapeutics, Inc. (PTCT) | 15-Feb-24 | Grant | 4,000 | -- | -- | 38% 10.5K to 14.5K | |
| 19-Apr-23 4:11 PM View: | Ptc Therapeutics, Inc. (PTCT) | 17-Apr-23 | Option Exercise | 11,429 | $18.01 | $205,836.00 | 109% 10.5K to 21.93K | |
| 19-Apr-23 4:11 PM View: | Ptc Therapeutics, Inc. (PTCT) | 17-Apr-23 | Planned Option Sale | 11,429 | $51.03 | $583,187.00 | (52%) 21.93K to 10.5K | |
| 04-Apr-23 4:07 PM View: | Ptc Therapeutics, Inc. (PTCT) | 31-Mar-23 | Option Exercise | 2,571 | $18.01 | $46,303.70 | 24% 10.5K to 13.07K | |
| 04-Apr-23 4:07 PM View: | Ptc Therapeutics, Inc. (PTCT) | 31-Mar-23 | Planned Option Sale | 2,571 | $50.05 | $128,672.00 | (20%) 13.07K to 10.5K | |
| 29-Mar-23 4:20 PM View: | Ptc Therapeutics, Inc. (PTCT) | 27-Mar-23 | Option Exercise | 10,000 | $27.05 | $270,500.00 | 95% 10.5K to 20.5K | |
| 29-Mar-23 4:20 PM View: | Ptc Therapeutics, Inc. (PTCT) | 27-Mar-23 | Planned Option Sale | 10,000 | $45.10 | $450,956.00 | (49%) 20.5K to 10.5K | |
| 09-Jan-23 4:10 PM View: | Ptc Therapeutics, Inc. (PTCT) | 05-Jan-23 | Grant | 4,000 | -- | -- | 62% 6.5K to 10.5K | |
| 20-May-22 4:15 PM View: | Tscan Therapeutics, Inc. (TCRX) | 18-May-22 | Private Purchase | 25,000 | $3.59 | $89,821.00 | 17% 146.57K to 171.57K | |
| 11-Jan-22 4:10 PM View: | Ptc Therapeutics, Inc. (PTCT) | 07-Jan-22 | Grant | 3,200 | -- | -- | 97% 3.3K to 6.5K | |
| 27-Dec-21 4:30 PM View: | Tscan Therapeutics, Inc. (TCRX) | 23-Dec-21 | Option Exercise | 48,670 | $1.97 | $95,879.90 | 50% 97.9K to 146.57K | |
| 09-Sep-21 4:43 PM View: | Tscan Therapeutics, Inc. (TCRX) | 08-Sep-21 | Market Purchase | 11,000 | $8.73 | $96,066.30 | 13% 86.9K to 97.9K | (2%) |
| 08-Jan-21 5:05 PM View: | Ptc Therapeutics, Inc. (PTCT) | 06-Jan-21 | Grant | 1,650 | -- | -- | 100% 1.65K to 3.3K | |
| 20-Oct-20 4:34 PM View: | Ptc Therapeutics, Inc. (PTCT) | 16-Oct-20 | Option Exercise | 27,000 | $11.02 | $297,510.00 | 1636% 1.65K to 28.65K | |
| 20-Oct-20 4:34 PM View: | Ptc Therapeutics, Inc. (PTCT) | 16-Oct-20 | Market Option Sale (Planned) | 27,000 | $51.54 | $1,391,540.00 | (94%) 28.65K to 1.65K | |
| 31-Jan-20 4:41 PM View: | Ptc Therapeutics, Inc. (PTCT) | 29-Jan-20 | Grant | 1,650 | -- | -- | 100% 0 to 1.65K | |
| 14-Dec-18 9:06 PM View: | Rocket Pharmaceuticals, Inc. (RCKT) | 13-Dec-18 | Market Sale | 38,768 | $15.19 | $588,886.00 | (29%) 133.93K to 95.16K | (273%) |
| 10-Dec-18 5:03 PM View: | Rocket Pharmaceuticals, Inc. (RCKT) | 07-Dec-18 | Market Option Sale | 4,923 | $14.91 | $73,401.90 | (4%) 138.85K to 133.93K | (280%) |
| 10-Dec-18 5:03 PM View: | Rocket Pharmaceuticals, Inc. (RCKT) | 06-Dec-18 | Market Option Sale | 52,809 | $15.15 | $800,056.00 | (28%) 191.66K to 138.85K | (274%) |
| 10-Dec-18 5:03 PM View: | Rocket Pharmaceuticals, Inc. (RCKT) | 28-Nov-18 | Option Exercise | 153,125 | -- | -- | 397% 38.53K to 191.66K | |
| 02-Apr-18 8:18 PM View: | Rocket Pharmaceuticals, Inc. (RCKT) | 02-Apr-18 | Option Exercise | 21,875 | -- | -- | 131% 16.66K to 38.53K | |
| 09-Jan-17 5:54 PM View: | Rocket Pharmaceuticals, Inc. (RCKT) | 06-Jan-17 | Market Purchase | 60,000 | $1.75 | $105,000.00 | 2170% 2.77K to 62.77K | 761% |
| 06-Jul-15 9:21 PM View: | Ptc Therapeutics, Inc. (PTCT) | 06-Jul-15 | Option Exercise | 15,000 | $10.85 | $162,750.00 | 174% 8.6K to 23.6K | |
| 06-Jul-15 9:21 PM View: | Ptc Therapeutics, Inc. (PTCT) | 06-Jul-15 | Market Option Sale (Planned) | 15,000 | $47.52 | $712,820.00 | (64%) 23.6K to 8.6K | 43% |
| 06-Jul-15 9:21 PM View: | Ptc Therapeutics, Inc. (PTCT) | 06-Jul-15 | Market Sale (Planned) | 8,604 | $47.52 | $408,874.00 | (100%) 8.6K to 0 | 43% |
| 23-Mar-15 5:58 PM View: | Ptc Therapeutics, Inc. (PTCT) | 23-Mar-15 | Market Sale (Planned) | 2,317 | $69.04 | $159,957.00 | (21%) 10.92K to 8.6K | 61% |
| 24-Mar-14 6:18 PM View: | Ptc Therapeutics, Inc. (PTCT) | 21-Mar-14 | Market Sale (Planned) | 2,317 | $30.93 | $71,666.00 | (18%) 13.24K to 10.92K | 12% |
| 01-Aug-12 11:53 AM View: | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition (change in control) | 90,835 | $14.25 | $1,294,400.00 | (100%) 90.83K to 0 | < 1% |
| 07-Dec-10 1:42 PM View: | THL Credit, Inc. (FCRD) | 06-Dec-10 | Market Purchase | 12,100 | $13.00 | $157,277.00 | 46% 26.4K to 38.5K | (18%) |
| 29-Nov-10 4:12 PM View: | THL Credit, Inc. (FCRD) | 24-Nov-10 | Market Purchase | 200 | $12.84 | $2,568.00 | < 1% 26.2K to 26.4K | (16%) |
| 24-Nov-10 10:11 AM View: | THL Credit, Inc. (FCRD) | 23-Nov-10 | Market Purchase | 100 | $12.83 | $1,283.00 | (< 1%) 26.3K to 26.2K | 16% |
| 24-Nov-10 10:11 AM View: | THL Credit, Inc. (FCRD) | 22-Nov-10 | Market Purchase | 101 | $12.84 | $1,296.34 | (< 1%) 26.2K to 26.1K | 16% |
| 22-Nov-10 4:37 PM View: | THL Credit, Inc. (FCRD) | 19-Nov-10 | Market Purchase | 499 | $12.84 | $6,406.17 | 2% 25.5K to 26.0K | (16%) |
| 22-Nov-10 4:37 PM View: | THL Credit, Inc. (FCRD) | 18-Nov-10 | Market Purchase | 11,400 | $12.84 | $146,365.00 | 81% 14.1K to 25.5K | (16%) |
| 18-Nov-10 5:05 PM View: | THL Credit, Inc. (FCRD) | 17-Nov-10 | Market Purchase | 5,478 | $12.84 | $70,324.40 | 64% 8.62K to 14.1K | (16%) |
| 18-Nov-10 5:05 PM View: | THL Credit, Inc. (FCRD) | 16-Nov-10 | Market Purchase | 8,622 | $12.84 | $110,706.00 | 100% 0 to 8.62K | (16%) |
| 10-Sep-10 2:01 PM View: | BioSphere Medical Inc. (BSMD) | 10-Sep-10 | Disposition | 20,055 | $4.38 | $87,840.90 | (100%) 20.05K to 0 | 0% |
| 14-Jul-10 1:35 PM View: | Human Genome Sciences Inc. (HGSI) | 12-Jul-10 | Grant | 85 | $32.86 | $2,793.10 | < 1% 90.75K to 90.83K | |
| 02-Jun-10 4:55 PM View: | Human Genome Sciences Inc. (HGSI) | 01-Jun-10 | Option Exercise | 17,653 | $5.76 | $101,731.00 | 24% 73.1K to 90.75K | |
| 12-Apr-10 4:48 PM View: | Human Genome Sciences Inc. (HGSI) | 12-Apr-10 | Grant | 97 | $32.86 | $3,187.42 | < 1% 73.0K to 73.1K | (26%) |
| 22-May-09 4:17 PM View: | BioSphere Medical Inc. (BSMD) | 20-May-09 | Option Exercise | 2,000 | $0.81 | $1,626.00 | 100% 0 to 2.0K | |
| 15-May-09 2:41 PM View: | BioSphere Medical Inc. (BSMD) | 14-May-09 | Grant | 2,500 | $0.01 | $25.00 | 16% 15.55K to 18.05K | |
| 16-Mar-09 5:13 PM View: | Human Genome Sciences Inc. (HGSI) | 13-Mar-09 | Market Purchase | 73,000 | $0.72 | $52,341.00 | 100% 0 to 73.0K | 3294% |
| 16-May-08 3:01 PM View: | BioSphere Medical Inc. (BSMD) | 14-May-08 | Grant | 2,500 | $0.01 | $25.00 | 19% 13.05K to 15.55K | 36100% |
| 12-Sep-07 4:33 PM View: | Sepracor, Inc. (SEPR) | 10-Sep-07 | Option Exercise | 50,000 | $6.24 | $312,000.00 | 88% 56.93K to 106.93K | |
| 12-Sep-07 4:33 PM View: | Sepracor, Inc. (SEPR) | 10-Sep-07 | Market Option Sale | 20,211 | $27.29 | $551,544.00 | (19%) 106.93K to 86.72K | 47% |